Reference
Argente-Escrig H, et al. Lenalidomide induced reversible parkinsonism, dystonia, and dementia in subclinical Creutzfeldt-Jakob disease. Journal of the Neurological Sciences 393: 140-141, 15 Oct 2018. Available from: URL: http://doi.org/10.1016/j.jns.2018.08.027 - Spain
Rights and permissions
About this article
Cite this article
Lenalidomide. Reactions Weekly 1722, 205 (2018). https://doi.org/10.1007/s40278-018-52534-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-52534-6